SYN023

SYN023 · Synermore Biologics Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for SYN023, covering 2019-02-27 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Real World Evidence Study of SYN023 in Children Exposed to Rabies